Keyphrases
AIDS/HIV
25%
Cost-effectiveness Analysis
25%
Effect Estimates
25%
External Validity
25%
Multiple Countries
25%
New Intervention
100%
Number-needed-to-treat
25%
Plan Implementation
100%
Pre-exposure Prophylaxis (PrEP)
25%
Profilaxis
25%
Public Health
25%
Randomized Controlled Trial
100%
Resource Allocation
50%
Resource Cost
25%
Subgroup Analysis
100%
Subgroup Effects
25%
Transportability
50%
Trial Population
50%
Medicine and Dentistry
Cost-Effectiveness Analysis
25%
Human Immunodeficiency Virus
25%
Numbers Needed to Treat
25%
Public Health
25%
Randomized Controlled Trial
100%
Subgroup Analysis
100%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
50%
Number Needed to Treat
50%
Randomized Controlled Trial
100%
Agricultural and Biological Sciences
Human Immunodeficiency Virus
50%
Resource Allocation
100%
Psychology
Public Health
50%
Resource Allocation
100%
Neuroscience
Human Immunodeficiency Virus
50%
Randomized Controlled Trial
100%